证券代码：600085 证券简称： 同仁堂 公告编号：2025-031 北京同仁堂股份有限公司关于控股孙公司获得柬埔寨传统药品注册许可证的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 北京同仁堂股份有限公司（以下简称公司）获悉，公司控股孙公司北京同仁堂国药有限公司（以下简称 同仁堂国药）收到柬埔寨王国（以下简称柬埔寨）卫生部药品与食品司颁发的《传统药品注册许可 证》，准许将同仁堂国药的"同仁堂安宫牛黄丸"在柬埔寨出售。现将相关情况公告如下： 同仁堂国药的同仁堂安宫牛黄丸之前已获得柬埔寨卫生部颁发的进口许可证，本次取得柬埔寨卫生部药 品与食品司签发的传统药品注册许可证后，同仁堂国药的同仁堂安宫牛黄丸可在柬埔寨出售。此举有助 于丰富同仁堂国药重点产品的分销渠道，有利于市场拓展。上述注册许可证的取得暂不会对公司生产经 营和业绩产生重大影响。 药品销售容易受到柬埔寨政策环境变化、汇率波动、市场竞争等因素的影响，敬请广大投资者注意投资 风险、谨慎投资。 特此公告。 1. 药品名称：同仁堂安宫牛黄丸 2. 许可证持有人名称及地址： ...

北京商报讯（记者 王寅浩 实习记者 宋雨盈）9月26日，同仁堂发布公告称，公司控股孙公司北京同仁 堂国药有限公司收到柬埔寨王国（以下简称"柬埔寨"）卫生部药品与食品司颁发的《传统药品注册许可 证》，准许将同仁堂国药的"同仁堂安宫牛黄丸"在柬埔寨出售，许可证有效期限至2028年9月11日止。 ...

Core Viewpoint - Tong Ren Tang has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing the sale of its "An Gong Niu Huang Wan" product in Cambodia [1] Group 1 - The license was issued to Beijing Tong Ren Tang Guo Yao Co., Ltd., a subsidiary of Tong Ren Tang [1] - This development indicates an expansion of Tong Ren Tang's market presence in Southeast Asia [1]

Core Viewpoint - Tong Ren Tang (600085.SH) has received a Traditional Medicine Registration License from the Ministry of Health of Cambodia, allowing its product "Tong Ren Tang An Gong Niu Huang Wan" to be sold in Cambodia [1] Group 1: Regulatory Approvals - The subsidiary Beijing Tong Ren Tang Guo Yao Co., Ltd. has obtained the Traditional Medicine Registration License, which follows the previously granted import license for the same product [1] - This license enables the distribution of Tong Ren Tang An Gong Niu Huang Wan in Cambodia, enhancing the product's market presence [1] Group 2: Market Expansion - The acquisition of the registration license is expected to enrich the distribution channels for key products of Tong Ren Tang Guo Yao, facilitating market expansion [1] - The impact of this license on the company's production operations and overall performance is not anticipated to be significant at this time [1]

Core Points - Tong Ren Tang Technologies (01666.HK) announced that its subsidiary, Tong Ren Tang Guo Yao, has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing the sale of "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia [1][2] Group 1 - The registered product is "Tong Ren Tang An Gong Niu Huang Wan" [2] - The license holder is Beijing Tong Ren Tang Guo Yao Co., Ltd., located at 14/F, 1405-1409, Convention Plaza, 1 Harbour Road, Wan Chai, Hong Kong [2] - The registration number is CAM N0004IT-25, and the license is valid until September 11, 2028 [2] Group 2 - The acquisition of the license will help enrich the distribution channels of the group's key products and facilitate market expansion [2] - The impact of this license on the group's production operations and performance is not expected to be significant [2] - Sales of the medicine may be influenced by changes in Cambodia's policy environment, exchange rate fluctuations, and market competition [2]

Core Insights - Tong Ren Tang Technology (01666.HK) announced that its subsidiary, Tong Ren Tang Guo Yao, has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing the sale of "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia [1][2] Group 1 - The drug "Tong Ren Tang An Gong Niu Huang Wan" is now authorized for sale in Cambodia, which will enhance the distribution channels for the company's key products and support market expansion [1][2] - The registration number for the license is CAM N0004IT-25, and it is valid until September 11, 2028 [2] - The acquisition of this license is not expected to have a significant impact on the company's production operations and performance in the short term [2] Group 2 - The sales of the drug may be influenced by changes in Cambodia's policy environment, exchange rate fluctuations, and market competition [2][3]

Core Viewpoint - Tong Ren Tang (600085.SH) has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing its subsidiary Beijing Tong Ren Tang Guo Yao Co., Ltd. to sell "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia [1] Group 1 - The approval from the Cambodian authorities marks a significant step for the company in expanding its international market presence [1] - The product "Tong Ren Tang An Gong Niu Huang Wan" is a traditional Chinese medicine, indicating the company's commitment to promoting traditional medicine abroad [1]

2025 年 9 月 27 日，北京同仁堂股份有限公司公告，其控股孙公司北京同仁堂国药有限公司收到柬埔寨 卫生部药品与食品司颁发的《传统药品注册许可证》，准许"同仁堂安宫牛黄丸"在柬出售。许可证编号 为 CAMN00041T - 25，有效期至 2028 年。此前该药品已获柬进口许可证，此次获注册许可有助于丰富 分销渠道、拓展市场，但暂不会对公司生产经营和业绩产生重大影响。同时，药品销售受政策、汇率、 竞争等因素影响，提醒投资者注意风险。 ...

同仁堂9月26日公告，公司控股孙公司同仁堂国药收到柬埔寨卫生部药品与食品司颁发的《传统药品注 册许可证》，准许将同仁堂国药的"同仁堂安宫牛黄丸"在柬埔寨出售。药品销售受多种因素影响，投资 者需注意投资风险。 ...

Core Viewpoint - Company Tong Ren Tang has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing the sale of "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia, which will enhance the distribution channels for the company's key products and support market expansion [1] Group 1 - The license permits the sale of "Tong Ren Tang An Gong Niu Huang Wan" under the guidance of licensed traditional Chinese medicine practitioners [1] - The Ministry of Health of Cambodia had previously issued an import license for "Tong Ren Tang An Gong Niu Huang Wan" [1] - The acquisition of the license will not have a significant immediate impact on the company's production operations and performance [1] Group 2 - The sales of the medicine may be influenced by changes in Cambodia's policy environment, exchange rate fluctuations, and market competition [1]